Literature DB >> 12084881

Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients.

L Migliore1, L Petrozzi, C Lucetti, G Gambaccini, S Bernardini, R Scarpato, F Trippi, R Barale, G Frenzilli, V Rodilla, U Bonuccelli.   

Abstract

BACKGROUND: Postmortem studies suggest excessive free radical toxicity in the substantia nigra of patients with PD. Increased lipid peroxidation and oxidative DNA damage have been reported in the CNS. Markers of oxidative stress have been identified in the blood of patients with PD.
OBJECTIVE: To assess the presence of spontaneous chromosome and primary or oxidative DNA damage in peripheral blood leukocytes of patients with untreated PD.
METHODS: Patients with de novo PD (20) and control subjects (16), matched for age, sex, and smoking habits, underwent cytogenetic analysis using the human lymphocyte micronucleus assay coupled with the fluorescence in situ hybridization technique and the Comet assay.
RESULTS: Compared with controls, patients with PD showed an increase in the incidence of spontaneous micronuclei (p < 0.001); single strand breaks (p < 0.001); and oxidized purine bases (p < 0.05). Fluorescence in situ hybridization analysis showed micronuclei harboring acentric fragments.
CONCLUSIONS: There is chromosomal, primary DNA damage and oxidative DNA damage demonstrable in lymphocytes of patients with untreated PD.

Entities:  

Mesh:

Year:  2002        PMID: 12084881     DOI: 10.1212/wnl.58.12.1809

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

2.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

3.  Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.

Authors:  Susan K Conroy; Brenna C McDonald; Dori J Smith; Lyndsi R Moser; John D West; Lisa M Kamendulis; James E Klaunig; Victoria L Champion; Frederick W Unverzagt; Andrew J Saykin
Journal:  Breast Cancer Res Treat       Date:  2012-12-22       Impact factor: 4.872

4.  LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.

Authors:  Yulia Y Tyurina; Daniel E Winnica; Valentina I Kapralova; Alexandr A Kapralov; Vladimir A Tyurin; Valerian E Kagan
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

5.  Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice.

Authors:  Rebeca Mejías; Javier Villadiego; C Oscar Pintado; Pablo J Vime; Lin Gao; Juan J Toledo-Aral; Miriam Echevarría; José López-Barneo
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

Review 6.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

7.  Ogg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP.

Authors:  Fernando Cardozo-Pelaez; Monica Sanchez-Contreras; Andrew B C Nevin
Journal:  Neurochem Int       Date:  2012-06-26       Impact factor: 3.921

8.  Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy.

Authors:  Francesca R Buttarelli; Annapia Circella; Clelia Pellicano; Dorina Tiple; Morena Giovannelli; Carlo Colosimo; Francesco E Pontieri
Journal:  J Neural Transm (Vienna)       Date:  2008-12-17       Impact factor: 3.575

9.  A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.

Authors:  Walter Maetzler; Joan Michelis; Juergen Tomiuk; Arthur Melms; Clemens Becker; Thomas Gasser; Claudia Schulte; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2009-04-02       Impact factor: 3.575

Review 10.  Emerging candidate biomarkers for Parkinson's disease: a review.

Authors:  Enrico Saracchi; Silvia Fermi; Laura Brighina
Journal:  Aging Dis       Date:  2013-10-09       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.